Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesDurable Medical Equipment (DME)Health Plan Upper Ohio Valley TEAS Coverage | Open…
    Ask Trek AI about this page
    CurrentHealth Plan of the Upper Ohio Valley, Inc.Policy N/A

    Transcutaneous Electrical Acupoint Stimulation (TEAS)

    Customize your policy alerts

    Sign up for all healthplanofupperohiovalley policy alerts

    Know when healthplanofupperohiovalley releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage, medical necessity, coding, documentation, and reimbursement considerations for prescription TEAS devices used to treat specified nausea and vomiting indications. It applies across all lines of business, subject to member benefits, applicable Medicare and West Virginia Medicaid requirements, and contract-specific rules.

    Policy Summary
    PayerHealth Plan of the Upper Ohio Valley, Inc.
    PolicyTranscutaneous Electrical Acupoint Stimulation (TEAS)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateAug 1, 2026
    Next Review DateJun 5, 2027
    Key ActionObtain a written, signed, and dated order before submitting the claim.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    3Covered clinical indications
    E0765Listed HCPCS code
    WV MedicaidExcluded population
    Prescription onlyCovered device type

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Face-to-face visit
    Required for postoperative or chemotherapy-induced nausea

    Coverage Criteria

    General coverage requirements

    For any item to be covered, all of the following general requirements must be met.

    • Benefit eligibility and medical necessity: The item is eligible for a defined Medicare or The Health Plan benefit category and is reasonable and necessary for diagnosis or treatment of an illness or injury or to improve the functioning of a malformed body member.
    • Applicable requirements: The item meets all other applicable Medicare and/or The Health Plan statutory and regulatory requirements.
    • Written order: The supplier receives a written, signed, and dated order before submitting a claim.Before claim submission
    • Supporting documentation: The treating practitioner provides thorough documentation substantiating medical necessity and appropriate use of the device.

    Covered clinical indications

    Prescription TEAS devices are covered when the applicable clinical indication and treatment-response criteria are met.

    Covered indications

    • Hyperemesis gravidarum: The device is prescribed for treatment of hyperemesis gravidarum that is unresponsive to conservative medical treatment.Unresponsive to conservative treatment

      Examples include a change in diet, ginger capsules, or vitamin B6.

    • Postoperative nausea: The device is prescribed for postoperative nausea that is unresponsive to antiemetics or other therapies, and a face-to-face encounter with the ordering physician has occurred.Unresponsive to antiemetics or other therapies

      Face-to-face encounter with the ordering physician required.

    • Chemotherapy-induced nausea:

    TEAS is not covered for West Virginia Medicaid members. This exclusion applies regardless of the clinical indication or device type.

    Over-the-counter and disposable TEAS devices are not covered. Coverage is limited to applicable prescription TEAS devices that meet the policy’s clinical and documentation requirements.

    TEAS devices are not covered for motion sickness or for any other indication not specifically listed in the coverage guidelines.

    TEAS use for motion sickness or other unlisted indications is not covered because efficacy has not been established in the peer-reviewed literature. In addition, many products marketed for these uses are disposable or available over the counter and therefore do not meet the definition of durable medical equipment.

    Coding Information

    CPT/HCPCS codesHCPCS
    E0765FDA APPROVED NERVE STIMULATOR, WITH REPLACEMENT BATTERIES, FOR TREATMENT OF NAUSEA AND VOMITING.

    Provider Actions and Billing Requirements

    Prior Authorization

    Applicable Precertification

    Suppliers must follow The Health Plan's precertification requirements, when applicable, before providing TEAS.

    Prior Authorization

    PDAC Authorization Review

    The Health Plan uses Medicare's PDAC contractor to review authorizations when applicable. Suppliers should contact the PDAC contractor for guidance on the correct coding of TEAS items.

    • PDAC guidance: dmepdac.com
    Documentation Required

    Order and Medical-Necessity Records

    Before a claim is submitted, the supplier must receive a written, signed, and dated order. The treating practitioner must also provide thorough documentation supporting the device's medical necessity and appropriate use.

    Background

    Transcutaneous electrical acupoint stimulation (TEAS) devices use low-level electrical pulses to stimulate the P6 acupoint and median nerve on the underside of the wrist. The policy describes prescription TEAS devices, including prescription versions of Relief Band and PrimaBella, for reducing nausea and vomiting in specified clinical circumstances.

    Device and Technology Definitions

    Relief Band
    Device typeA watch-like device worn on the ventral side of the wrist.
    StimulationEmits a low-level electrical current across two small electrodes on its underside.
    MechanismThe electrical current stimulates the median nerve.
    PrimaBella
    Device typeA transcutaneous electrical acupoint stimulation (TEAS) device.
    StimulationEmits gentle pulses transmitted through the median nerve on the underside of the wrist.
    Physiologic action

    Medical Necessity

    TEAS medical necessity

    A prescription TEAS device is medically necessary when one of the following covered indication pathways is met.

    Medical-necessity indications

    • Hyperemesis gravidarum: The device is prescribed for hyperemesis gravidarum, and the condition is unresponsive to conservative medical treatment.Unresponsive to conservative treatment

      Conservative treatment may include a change in diet, ginger capsules, or vitamin B6.

    • Postoperative nausea: The device is prescribed for postoperative nausea, the nausea is unresponsive to antiemetics or other therapies, and a face-to-face encounter with the ordering physician has occurred.Unresponsive to antiemetics or other therapies

      Face-to-face encounter with the ordering physician required.

    Documentation Requirements

    Documentation Required

    Complete the order and supporting records

    Obtain the written, signed, and dated order before submitting the claim, and ensure it identifies the prescribed item. The treating practitioner’s records must thoroughly substantiate medical necessity and appropriate device use.

    Documentation Required

    Record the ordering-physician encounter and treatment failure

    For postoperative or chemotherapy-induced nausea, the records must document a face-to-face encounter with the ordering physician and failure of antiemetics or other therapies.

    Not Covered

    Not covered: over-the-counter TEAS devices; disposable TEAS devices; and TEAS for West Virginia Medicaid members.

    Policy Summary
    PayerHealth Plan of the Upper Ohio Valley, Inc.
    PolicyTranscutaneous Electrical Acupoint Stimulation (TEAS)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateAug 1, 2026
    Next Review DateJun 5, 2027
    Key ActionObtain a written, signed, and dated order before submitting the claim.
    SourceLink
    On This Page
    Coverage CriteriaCoding InformationProvider Actions and Billing RequirementsBackgroundDevice and Technology DefinitionsMedical NecessityDocumentation RequirementsNot Covered
    The device is prescribed for chemotherapy-induced nausea that is unresponsive to antiemetics or other therapies, and a face-to-face encounter with the ordering physician has occurred.
    Unresponsive to antiemetics or other therapies

    Face-to-face encounter with the ordering physician required.

    • Retain the written order and supporting medical-necessity records for the claim.

    Unsupported block type: documentation

    Denial Risk

    Noncoverage Notification

    Before dispensing a device that is not covered, the provider must notify the member verbally and in writing that the specific service is not covered. Providers may be held financially responsible if this notification is not provided before dispensing.

    • Submit the notification information upon request.
    Denial Risk

    Unlisted Indications Not Covered

    TEAS is not covered for motion sickness or any indication other than those listed in the policy because efficacy has not been established in the peer-reviewed literature.

    • Covered indications listed in the policy are treatment-resistant hyperemesis gravidarum, postoperative nausea, and chemotherapy-induced nausea.
    Denial Risk

    OTC or Disposable Devices Not Covered

    Over-the-counter and disposable TEAS devices are not covered. Items commonly used for these indications do not meet the Medicare or The Health Plan definition of durable medical equipment.

    Denial Risk

    West Virginia Medicaid Exclusion

    Transcutaneous electrical acupoint stimulation is not covered for West Virginia Medicaid members.

    Documentation Required

    Failure to Demonstrate Treatment Resistance

    Coverage requires documentation that the condition was unresponsive to the applicable conservative treatment or other therapy.

    • Hyperemesis gravidarum: document failure of conservative treatment, such as a change in diet, ginger capsules, or vitamin B6.
    • Postoperative nausea: document failure of antiemetics or other therapies.
    • Chemotherapy-induced nausea: document failure of antiemetics or other therapies.
    Billing Rule

    General Benefit and Medical-Necessity Requirements

    For TEAS to be covered, the item must qualify under a defined Medicare or The Health Plan benefit category, be reasonable and necessary for diagnosis or treatment of an illness or injury or to improve the functioning of a malformed body member, and satisfy all other applicable statutory and regulatory requirements.

    • Individual product-line certificates of coverage may contain additional benefit exclusions.
    • Applicable Medicare National Coverage Determinations, Local Coverage Determinations, and West Virginia Bureau for Medical Services guidelines control if they conflict with this policy.
    The pulses travel to the emetic center in the brain and regulate nausea signaling between the brain and stomach, restoring normal stomach rhythm and providing relief of nausea and vomiting.
    OperationThe device can be turned on and off according to symptoms.
    Transdermal neuromodulation
    Manufacturer terminologyThe manufacturer of Relief Band refers to this stimulation as transdermal neuromodulation.
    Stimulation siteThe stimulation is delivered through the underside of the wrist to the median nerve.
    PurposeThe stimulation is used to regulate nausea signaling and help relieve nausea and vomiting.
    Chemotherapy-induced nausea: The device is prescribed for chemotherapy-induced nausea, the nausea is unresponsive to antiemetics or other therapies, and a face-to-face encounter with the ordering physician has occurred.Unresponsive to antiemetics or other therapies

    Face-to-face encounter with the ordering physician required.